<code id='1593A77144'></code><style id='1593A77144'></style>
    • <acronym id='1593A77144'></acronym>
      <center id='1593A77144'><center id='1593A77144'><tfoot id='1593A77144'></tfoot></center><abbr id='1593A77144'><dir id='1593A77144'><tfoot id='1593A77144'></tfoot><noframes id='1593A77144'>

    • <optgroup id='1593A77144'><strike id='1593A77144'><sup id='1593A77144'></sup></strike><code id='1593A77144'></code></optgroup>
        1. <b id='1593A77144'><label id='1593A77144'><select id='1593A77144'><dt id='1593A77144'><span id='1593A77144'></span></dt></select></label></b><u id='1593A77144'></u>
          <i id='1593A77144'><strike id='1593A77144'><tt id='1593A77144'><pre id='1593A77144'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:17852
          Adam's take main illustration
          Molly Ferguson/STAT

          Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

          In other words, a lot like the content below. I’m really excited to get started and I hope you’ll find the newsletter worthy of your inbox real estate.

          advertisement

          This week: A deep dive into the bull and bear sides of the Applied Therapeutics debate, and another well-deserved swipe at Cassava Sciences and its entirely ridiculous Alzheimer’s drug candidate.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          CDC: Uninsured rate hit 'record low' right as states cut Medicaid
          CDC: Uninsured rate hit 'record low' right as states cut Medicaid

          JaeC.Hong/APRoughly7.7%ofAmericansdidn’thaveanyhealthinsuranceasofthispastMarch—a“recordlow”uninsure

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          What the cancer research community can learn from the Covid response

          TinaReed,PaulKluetz,JohnOyler,andSolangePetersspeakattheMilkenInstituteFutureofHealthSummit.Screenca